LDL C

Related by string. * LDLs . LDLS : LDL cholesterol levels . elevated LDL cholesterol . aggressively lowering LDL . lowering LDL . lousy LDL cholesterol . lowering LDL cholesterol . oxidized LDL . LDL cholesterol lowering . oxidized LDL cholesterol / CD . CS . cd . C. . CER . c . Cs . CED : c o . b c . c Copyright Thomson Reuters . C ounty . #-#-# #ET Copyright c . C hris . disc CD changer . Answer c o * cholesterol LDL C *

Related by context. All words. (Click for frequent words.) 76 LDL cholesterol 74 LDL 72 HDL C 71 cholesterol LDL C 69 LDL cholesterol levels 69 low density lipoprotein 68 HbA1c 68 HbA1c levels 67 triglyceride levels 66 A1C levels 66 HDL cholesterol 66 HbA 1c 65 triglycerides 65 sUA 65 serum uric acid 64 statin therapy 64 baseline HbA1c 64 serum cholesterol 64 Hb A1C 64 mg dL 64 bad cholesterol LDL 64 serum calcium 64 A1C 64 density lipoprotein cholesterol 64 allopurinol 64 elevated triglycerides 63 serum urate 63 serum phosphate 63 apolipoprotein B 63 hemoglobin A1c HbA1c 63 serum triglycerides 63 hemoglobin A1c levels 63 HbA1C 63 platelet inhibition 63 serum phosphorus 63 fasting plasma glucose FPG 63 hypertensive patients 62 fasting plasma glucose 62 glycemic control 62 antihypertensive medications 62 glycosylated hemoglobin HbA1c 62 serum phosphate levels 62 primary hypercholesterolemia 62 hypertensives 62 density lipoprotein cholesterol HDL 62 Lp PLA2 62 mmHg 61 glycated hemoglobin 61 tHcy 61 lipid levels 61 serum LDL cholesterol 61 serum calcium levels 61 serum urate levels 61 proteinuria 61 cholesterol 61 glycemia 61 valsartan 61 urinary oxalate 61 cardiovascular morbidity 61 atherogenic lipids 61 blood Phe 61 irbesartan 60 hsCRP 60 glycated hemoglobin levels 60 C reactive protein 60 elevated LDL 60 elevated LDL cholesterol 60 LDL Cholesterol 60 hs CRP 60 hypercholesterolemia 60 LDL lowering 60 antihypertensive therapy 60 serum potassium 60 serum phosphorus levels 60 alanine aminotransferase ALT 60 density lipoprotein HDL cholesterol 60 uric acid levels 60 mm Hg 60 A1c levels 60 fasting triglyceride levels 60 BENICAR HCT 60 cardiovascular mortality 60 LVEF 60 ACE inhibitor ramipril 60 fasting glucose levels 60 apoB 60 fasting blood glucose 60 triglyceride 59 #/#mmHg 59 elevated triglyceride levels 59 serum triglyceride levels 59 total cholesterol LDL 59 lipid lowering therapy 59 glycosylated hemoglobin 59 blood Phe levels 59 systolic BP 59 #.#mmol L [002] 59 aldosterone 59 LDL cholesterol lowering 59 apo B 59 serum concentrations 59 -#.# mg dL [002] 59 homocysteine levels 59 ezetimibe 59 A1c 59 lipoprotein 59 statin monotherapy 59 fasting glucose 59 benazepril 59 olmesartan 58 mmol l 58 lowering LDL cholesterol 58 LDLs 58 normotensive 58 angiotensin converting enzyme 58 atherogenic dyslipidemia 58 cystatin C 58 glycated hemoglobin HbA1c 58 lactate dehydrogenase LDH 58 resistant hypertension 58 losartan 58 dyslipidaemia 58 hydroxyvitamin D levels 58 LDL cholesterol LDL 58 serum creatinine levels 58 infarct size 58 serum testosterone 58 mean serum phosphorus 58 homocysteine concentrations 58 triglyceride TG 58 serum uric acid sUA 58 lipid parameters 58 rosuvastatin 58 lumbar spine BMD 58 hsCRP levels 58 blood phenylalanine Phe 58 blood lipids 58 platelet reactivity 58 ApoB 58 paricalcitol 58 ramipril 58 fasting insulin 58 hemoglobin A1c 58 β blockers 58 serum leptin 58 atherosclerosis 57 mixed hyperlipidemia 57 antihypertensive agents 57 lipid lowering drugs 57 rosuvastatin #mg 57 #mg/dL [002] 57 transferrin saturation 57 HOMA IR 57 urate levels 57 hemoglobin A1C 57 #mg/dL [001] 57 lipid lowering 57 serum vitamin D 57 serum glucose 57 albuminuria 57 dapagliflozin plus 57 candesartan 57 ULORIC 57 antihypertensive drugs 57 hyperkalemia 57 CLA supplementation 57 HbA 1C 57 ATACAND 57 serum lipid levels 57 pioglitazone 57 intima media thickness 57 DASH diet 57 colesevelam HCl 57 T2DM 57 troponin T 57 systolic blood pressure 57 sulphonylurea 57 nicardipine 57 triglycerides TG 57 angiotensin converting enzyme ACE 57 K DOQI 57 HbA 1c levels 57 microalbuminuria 57 lipid lowering agents 57 umol L 57 SERCA2a 57 aminotransferases 57 BENICAR 57 mixed dyslipidemia 57 impaired fasting glucose 57 mg dl 57 cholesterol LDL 57 metformin 57 NPH insulin 57 HDL Cholesterol 57 nitrotyrosine 56 amlodipine 56 neutrophil counts 56 triacylglycerol 56 serum IGF 56 ejection fraction 56 VLDL cholesterol 56 baseline serum creatinine 56 plasma triglycerides 56 #mmHg [002] 56 azacitidine 56 subclinical hypothyroidism 56 statin 56 VLDL C 56 #.#/#.# mmHg [001] 56 plasma folate 56 tirofiban 56 metabolic syndrome 56 mL/min/#.# m 2 56 lipoprotein Lp 56 serum sodium 56 elevated CRP 56 thrombotic events 56 dose statin therapy 56 mm Hg systolic 56 insulin detemir 56 rimonabant #mg 56 iPTH 56 dyslipidemia 56 #.#mg/dL 56 HoFH 56 serum PTH 56 atorvastatin 56 #.#mmol L [001] 56 diastolic blood pressures 56 lymphocyte counts 56 simvastatin 56 nonfasting triglyceride levels 56 antihypertensive medication 56 angiotensin converting enzyme inhibitors 56 hemoglobin levels 56 eGFR 56 lipid abnormalities 56 HCTZ 56 nonfasting triglycerides 56 glomerular filtration rate 56 systolic 56 moderate renal impairment 56 fetuin 56 NCEP ATP III 56 bosentan 56 urinary albumin 56 CK MB 56 Lp PLA 2 56 C Reactive Protein 56 lipid 56 isolated systolic hypertension 56 glomerular filtration 56 pg mL 56 insulin sensitivity 56 metformin monotherapy 56 adiponectin 56 tolvaptan 56 adalimumab 56 vWF 56 familial hypercholesterolemia 56 cholesterols 56 microvascular complications 56 telmisartan 56 left ventricular hypertrophy 56 serum retinol 56 total cholesterol triglycerides 56 dose atorvastatin 56 left ventricular dysfunction 56 alanine aminotransferase 56 lowering blood glucose 56 nephrotoxicity 56 serum CRP 56 bone resorption 55 macrovascular 55 RBP4 55 insulin glargine 55 CrCl 55 prehypertension 55 dietary sodium 55 hypercholesterolaemia 55 μmol L 55 hyperphenylalaninemia HPA due 55 lipid profiles 55 candesartan cilexetil 55 highest tertile 55 creatinine clearance 55 albumin excretion 55 atherogenic 55 MADRS score 55 sUA levels 55 hemoglobin concentration 55 fluvastatin 55 Fibrates 55 ACE inhibitors 55 intact parathyroid hormone 55 maximally tolerated doses 55 glucose lowering 55 atorvastatin #mg 55 insulin resistance 55 elevated homocysteine 55 nmol L 55 cholesterol HDL 55 HbA1C levels 55 serum folate concentrations 55 EpCAM expression 55 glycosylated hemoglobin levels 55 hip BMD 55 chlorambucil 55 arterial stiffness 55 #mmHg [001] 55 dietary fat 55 thyrotropin 55 hepatic glucose production 55 calcium supplementation 55 hemoglobin concentrations 55 coronary artery disease 55 CsA 55 eplerenone 55 lispro 55 systemic embolism 55 serum phosphorous 55 plasma glucose levels 55 plasma homocysteine 55 subclinical atherosclerosis 55 cholesterol LDL cholesterol 55 glycemic 55 serum folate 55 platelet aggregation 55 bezafibrate 55 LDL HDL ratio 55 mIU L 55 teriflunomide 55 HMG CoA reductase inhibitor 55 adenoma recurrence 55 platelet counts 55 adiponectin levels 55 Ramipril 55 blood glucose levels 55 systolic hypertension 55 aliskiren 55 fructose diet 55 PASI scores 55 statins 55 Hb levels 55 homocysteine 55 mmol L 55 diastolic BP 55 TC HDL 55 diabetes mellitus 55 OADs 55 pulmonary exacerbations 54 aspartate aminotransferase AST 54 triglyceride concentrations 54 thyroxine 54 MULTAQ 54 postprandial glucose 54 dose clopidogrel 54 LEXIVA r 54 hyperglycaemia 54 Cmax 54 perindopril 54 complete cytogenetic response 54 β blocker 54 A1Cs 54 homozygous familial hypercholesterolemia 54 alpha1 54 clusterin 54 PlGF 54 virologic failure 54 HDL 54 plasma concentrations 54 density lipoprotein 54 coronary heart 54 atherothrombotic events 54 #mg/dl 54 angiotensin receptor blocker ARB 54 serum triglyceride 54 virologic response 54 serum HBV DNA 54 mmHg diastolic 54 c reactive protein 54 thyroid stimulating hormone 54 oxidized LDL 54 CYP#C# [001] 54 hypertriglyceridemia 54 sweat chloride 54 inflammatory lesions 54 baseline A1C 54 ischemic stroke 54 LTB4 54 TSP1 54 hyperphosphatemia 54 folate 54 systolic dysfunction 54 nonvertebral fractures 54 carotid IMT 54 pharmacokinetic PK profile 54 atherosclerotic 54 triacylglycerol concentrations 54 isoprostane 54 lipoprotein levels 54 LEXIVA 54 anticoagulation 54 fasting triglycerides 54 lipid lowering medications 54 ApoA1 54 mEq L 54 contrast induced nephropathy 54 CVD mortality 54 angiotensin II 54 asymptomatic carotid stenosis 54 inflammatory biomarkers 54 mm Hg diastolic 54 Serum creatinine 54 advanced adenomas 54 XIENCE V PROMUS Stent 54 nondiabetic patients 54 atheroma volume 54 severe renal impairment 54 left ventricular ejection 54 systolic pressure 54 creatinine ratio 54 chlorthalidone 54 glimepiride 54 binary restenosis 54 HIV RNA 54 vildagliptin 54 renin angiotensin aldosterone 54 hypertension 54 CIMZIA ™ 54 KIF6 carriers 54 ezetimibe Zetia 54 transaminases 54 angiotensin 54 sitagliptin 54 elevated uric acid 54 hydroxyvitamin D 54 cystatin 54 tocilizumab 54 hyperglycemia 54 natriuretic peptide 54 hemoglobin 54 apolipoproteins 54 Pioglitazone 54 plasma HCV RNA 54 preserved ejection fraction 54 UACR 54 trans fat intake 54 vascular inflammation 54 macroalbuminuria 54 mmHg systolic 54 antidiabetic drugs 54 macrovascular events 54 triglyceride concentration 54 lumbar spine bone 54 VLDL 54 PREZISTA r 54 complete cytogenetic 54 plasma leptin 53 CCyR 53 Homocysteine 53 HDL2 53 ABCB1 53 prediabetes 53 rHuPH# 53 HMG CoA reductase inhibitors 53 clinically meaningful 53 antidiabetic therapy 53 plasma lipid 53 plasma urate 53 oral antidiabetic medication 53 undetectable viral 53 g dl 53 carotid plaque 53 liver histology 53 NATRECOR R 53 Cardiovascular Risk 53 vertebral fracture 53 elevated hsCRP 53 Atacand 53 leukocyte count 53 dose cytarabine 53 thromboembolic events 53 folate intake 53 mmol L. 53 cinacalcet 53 angiotensin converting enzyme inhibitor 53 statin medications 53 milligrams deciliter 53 Fasting glucose 53 Prehypertension 53 dose colchicine 53 metformin sulfonylurea 53 aspartate aminotransferase 53 Telmisartan 53 CDAI score 53 SGLT2 53 urinary albumin excretion 53 serum bilirubin 53 Welchol 53 apoC III 53 lanthanum carbonate 53 levosimendan 53 blood glucose concentrations 53 ACR# response 53 fasting hyperglycemia 53 sustained virologic response 53 HER2 expression 53 intracranial hemorrhage ICH 53 fondaparinux 53 per deciliter mg 53 pramlintide 53 Low Density Lipoprotein Cholesterol 53 endothelial function 53 fibrate 53 urinary excretion 53 urate lowering therapy 53 dietary sodium intake 53 periprocedural 53 intraocular pressure 53 PSA nadir 53 Lupuzor ™ 53 morphometric vertebral fractures 53 left ventricular systolic 53 mL min 53 serum TSH 53 anemia hemoglobin 53 unfractionated heparin 53 Dasatinib 53 poor metabolizers 53 non fasting triglycerides 53 plasma uric acid 53 HBV DNA levels 53 subclinical hyperthyroidism 53 PSADT 53 diastolic blood pressure 53 HIV HCV coinfected 53 airway hyperresponsiveness 53 KOMBIGLYZE XR 53 Stop Hypertension diet 53 SHBG levels 53 8 OHdG 53 renal impairment 53 hypoglycemic events 53 HCV RNA 53 sulfonylurea 53 hydroxymethyl coenzyme 53 fluticasone salmeterol 53 LDL oxidation 53 Cholesterol 53 beta blocker therapy 53 sodium intake 53 ng dL 53 molecular weight heparins 53 salt intake 53 fasting plasma 53 mineral density 53 Aliskiren 53 acute coronary syndrome 53 salmeterol fluticasone propionate 53 NAFLD 53 fosamprenavir 53 HBV DNA 53 mcg BID 53 carotid intima media 53 CRESTOR #mg 53 undetectable HCV RNA 53 Stop Hypertension DASH diet 53 recurrent VTE 53 statin simvastatin 53 calcium intake 53 apolipoprotein AI 53 pmol L 53 lipids 53 sustained virological response 53 eprotirome 53 corticosteroid dose 53 TNFa 53 thyrotropin levels 53 hypoglycemia 53 ivabradine 53 trans palmitoleic acid 53 Triglycerides 53 intensive statin therapy 53 disease progression 53 plasma renin activity 53 Low Density Lipoprotein 53 sirolimus 53 leukotriene 53 T2D 53 steroid dexamethasone 53 waist circumference 53 NYHA class 53 residual platelet reactivity 53 folate concentrations 53 achieved ACR# 53 TZDs 52 thiazide diuretic 52 atherosclerotic disease 52 FOSRENOL ® 52 IL 1ß 52 indapamide 52 elevated ALT 52 EDSS score 52 creatinine 52 daunorubicin 52 lowers LDL cholesterol 52 lupus nephritis 52 hypogonadal men 52 acarbose 52 peptide BNP 52 thickness CIMT 52 Hemoglobin A1c 52 calcium channel 52 lung function 52 metabolic parameters 52 myocardial infarction 52 ezetimibe simvastatin 52 elevated creatinine 52 sitosterol 52 abacavir lamivudine 52 mg BID dose 52 ximelagatran 52 hyperlipidemia 52 nondiabetic 52 serum homocysteine 52 CK # plasma concentrations 52 CETP inhibition 52 imatinib therapy 52 HDL cholesterol HDL 52 hypercalcemia 52 pg ml 52 gliclazide 52 triiodothyronine 52 EDARBI 52 aminotransferase ALT 52 creatinine levels 52 concomitant medications 52 BH4 52 adiponectin concentrations 52 serum cortisol 52 glucocorticoid 52 urine albumin 52 Aldosterone 52 x ULN 52 magnesium intake 52 apolipoprotein A1 52 CD4 + CD# 52 rolofylline 52 angiotensin receptor blockers ARBs 52 omalizumab 52 idraparinux 52 Procoralan 52 IL6 52 acute coronary syndromes 52 dietary folate 52 NYHA Class II 52 Combination therapy 52 coadministration 52 symptomatic VTE 52 carotid artery intima media 52 xanthine oxidase inhibitor 52 urinary N telopeptide 52 TNFalpha 52 cTnT levels 52 GRK2 52 fenofibric acid 52 ARB telmisartan 52 elevated fasting glucose 52 incretin 52 CD4 + cell 52 azacytidine 52 severe hypoglycemia 52 GP IIb IIIa inhibitors 52 diastolic function 52 D dimer 52 STRIDE PD 52 TAXUS Express Stent 52 rFVIIa 52 insulin sensitizing 52 IDDM 52 serum selenium 52 IFN beta 52 E selectin 52 AVODART 52 LDL cholesterol HDL cholesterol 52 detemir 52 autoantibody levels 52 MetS 52 cardiometabolic risk 52 clopidogrel 52 systemic corticosteroid 52 LV dysfunction 52 dosing frequency 52 cholesterol absorption 52 atorvastatin Lipitor 52 COPAXONE R 52 cardiovascular hospitalizations 52 peginterferon alfa 2a 52 AZOR 52 SHBG 52 VEGF receptor 52 calcium intakes 52 eNOS 52 adjunctive placebo 52 thiazide diuretics 52 seropositive patients 52 oral antidiabetes 52 canakinumab 52 extrapyramidal symptoms 52 oral allopurinol 52 #.#ng/ml 52 hepcidin 52 antihypertensives 52 GFT# 52 IGFBP 3 52 darapladib 52 statistical significance p 52 plasma glucose 52 reflux symptoms 52 DCCR 52 NovoLog ® Mix 52 carotid stenosis 52 alagebrium 52 glitazones 52 fat diet 52 Victoza R 52 alkaline phosphatase 52 ng mL 52 GnRH agonists 52 mucosal healing 52 interferon IFN 52 mealtime insulin 52 CANCIDAS 52 SGPT 52 #mg/day [002] 52 serum ferritin 52 HBeAg seroconversion 52 diastolic heart 52 glycemic load 52 AEGR 52 density lipoproteins 52 MAO B 52 Triglyceride levels 52 secondary hyperparathyroidism 52 creatine kinase 52 rosuvastatin Crestor 52 HER3 52 AT1R 52 lomitapide 52 IGFBP 52 Rasilez Tekturna 52 IIIa inhibitor 52 dietary calcium intake 52 serum PSA 52 ejection fractions 52 Apidra ® 52 Candesartan 52 TMC# r 52 proliferative diabetic retinopathy 52 lowers LDL 52 sodium glucose cotransporter 52 alpha Gal 52 mRNA expression 52 bioavailable testosterone 52 renin 52 exhaled nitric oxide 52 ritonavir boosted 52 hemoglobin Hb 52 IgE 52 raltegravir 52 microvascular disease 52 lowest tertile 52 metformin sulphonylurea 52 angiographic restenosis 52 oral antidiabetic drugs 52 coronary blockages 52 VAPRISOL 52 thyroglobulin 52 bile acid sequestrant 52 myeloperoxidase 52 B7 H3 52 urinary calcium 52 ALLHAT 52 Lipoprotein 52 achieved statistical significance 52 ng ml 52 pyridostigmine 52 SGOT 52 Adiponectin 52 esomeprazole 52 saturated fatty acids 52 verapamil 52 cardiovascular hospitalization 52 angiotensin receptor blocker 52 Unified Parkinson Disease 51 TAXUS Stent 51 nmol liter 51 severe exacerbations 51 carbohydrate diets 51 ischemic 51 cytopenias 51 NATRECOR ® 51 interferon alfa 2b 51 mean baseline HbA1c 51 log# IU mL 51 PRADAXA 51 myocardial infarction MI 51 active comparator 51 clinically meaningful reductions 51 alteplase 51 ruboxistaurin 51 fibrates 51 Abeta# 51 pravastatin 51 rosuvastatin calcium 51 serum lipid 51 Triglyceride 51 serum potassium levels 51 Hyperlipidemia 51 mg BID 51 monounsaturated fatty acids 51 serum clusterin levels 51 Psoriasis Area 51 chronic periodontitis 51 IFN α 51 lopinavir 51 ACE Inhibitor 51 serum prostate 51 postmenopausal breast cancer 51 Epanova 51 lymphocyte count 51 immunomodulation 51 serum ALT 51 alanine transaminase ALT 51 CLA isomers 51 tamsulosin 51 TNF α 51 inflammatory markers 51 triglycerides HDL 51 lipid lowering therapies 51 hypogonadal 51 aldosterone antagonist 51 aspirin clopidogrel 51 rilonacept 51 angiotensin II receptor blockers 51 glyburide 51 mg dose 51 prospectively defined 51 GSTM1 51 mm Stent 51 events MACE 51 dose ritonavir 51 nilotinib 51 intra ocular pressure 51 arterial thromboembolic events 51 REYATAZ r arm 51 bronchodilation 51 vitamin D intake 51 angiotensin II receptor blocker 51 colorectal adenoma 51 serum aminotransferase levels 51 CIMZIA TM 51 ZD# [001] 51 ischemic cardiomyopathy 51 prespecified 51 fulvestrant 51 specific antigen PSA 51 hyperuricemia 51 nitric oxide synthase 51 Primary Hypercholesterolemia 51 ferritin 51 octreotide LAR 51 serum creatinine 51 AST ALT 51 follicle stimulating hormone FSH 51 albumin excretion rate 51 dietary fiber intake 51 heparanase 51 APTIVUS r 51 antibody titers 51 deferiprone 51 LDL cholesterol concentrations 51 onset diabetes mellitus 51 oxycodone CR 51 estimated GFR 51 IV bisphosphonates 51 simvastatin ezetimibe 51 retinal thickness 51 Calcium intake 51 nonfatal MI 51 #mg dose [001] 51 NNT = 51 lipid lowering medication 51 undetectable viral load 51 serum lipids 51 viral loads 51 metabolic abnormalities 51 vitamin D supplementation 51 coronary disease 51 plasma creatinine 51 microglial activation 51 saturated fat intake 51 Hgb 51 OGTT 51 myopathy rhabdomyolysis 51 PREZISTA r arm 51 latanoprost 51 severe psoriasis 51 CC genotype 51 transaminase levels 51 NNRTI resistance 51 coronary stenosis 51 SUVmax 51 peginterferon 51 D2 receptors 51 trandolapril 51 glucose homeostasis 51 TREDAPTIVE 51 undetectable HBV DNA 51 UCP2 51 deferasirox 51 SCr 51 PON1 enzyme 51 d4T 51 VICTRELIS 51 everolimus eluting stents 51 mycophenolate mofetil 51 post prandial glucose 51 left ventricular LV 51 apoA 51 Cardiovascular Events 51 lowers blood glucose 51 biphasic insulin aspart 51 #mg doses [002] 51 amino acid homocysteine 51 calcified plaque 51 glucose uptake 51 #mg/day [001] 51 PYY 51 lopinavir r arm 51 pulmonary capillary wedge 51 LDL HDL 51 gastric pH 51 S#A# [002] 51 HDL LDL ratio 51 plasma lipids 51 CCR3 51 LY# [002] 51 Hb 51 elevated troponin 51 angiotensin receptor blockers 51 ACR# responses 51 chloride secretion 51 fraction LVEF 51 abdominal adiposity 51 anacetrapib 51 dietary intake 51 Primary endpoints 51 airway hyper responsiveness 51 posaconazole 51 liver enzymes 51 serum magnesium 51 obese adolescents 51 certolizumab 51 alkaline phosphatase ALP 51 systolic blood pressures 51 #.#mmol l [002] 51 fibrosis 51 LDL receptor 51 fatal myocardial infarction 51 bronchial hyperresponsiveness 51 fenretinide 51 mg d 51 plasma renin 51 troponin 51 Serum calcium 51 pressor response 51 atherosclerotic plaques 51 ACh 51 antihypertensive 51 renal function 51 antioxidant supplementation 51 Low density lipoprotein 51 GnRH agonist 51 elevated serum creatinine 51 titrated glipizide 51 adiposity 51 NYHA functional class 51 normal ULN 51 amyloid deposition 51 alpha defensins 51 paraprotein 51 interferon alfa 51 hyperoxaluria 51 log# copies mL 51 fat vegan diet 51 RBP4 levels

Back to home page